Federated Hermes, Inc. Ionis Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$33.58 - $41.2 $272,199 - $333,967	-8,106 Reduced 30.5%	18,473 $660,000
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $16,778 - $21,027	452 Added 1.73%	26,579 $1 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $40,559 - $54,012	-1,110 Reduced 4.08%	26,127 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $281,426 - $381,625	8,875 Added 48.33%	27,237 $1.01 Million
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $421,576 - $522,597	14,109 Added 331.74%	18,362 $680,000
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $5,467 - $6,609	163 Added 3.99%	4,253 $143,000
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $141,268 - $193,252	4,090 New	4,090 $163,000
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $324,011 - $486,131	-7,622 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $815 - $1,084	18 Added 0.24%	7,622 $431,000
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $11,957 - $15,863	-252 Reduced 3.21%	7,604 $361,000
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $2.36 Million - $3.08 Million	-50,379 Reduced 86.51%	7,856 $463,000
Q1 2020 May 13, 2020	BUY	$41.6 - $63.4 $2.05 Million - $3.12 Million	49,217 Added 545.76%	58,235 $2.75 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $393,051 - $476,405	7,299 Added 424.61%	9,018 $545,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $7.62 Million - $9.31 Million	-129,104 Reduced 98.69%	1,719 $103,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $8.51 Million - $11.8 Million	-137,055 Reduced 51.16%	130,823 $8.41 Million
Q1 2019 May 10, 2019	BUY	$52.92 - $81.17 $7.05 Million - $10.8 Million	133,178 Added 98.87%	267,878 $21.7 Million
Q4 2018 Feb 13, 2019	BUY	$43.37 - $59.54 $5.84 Million - $8.02 Million	134,700 New	134,700 $7.28 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account